Challenges to achieving clinical transplantation tolerance.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

19 citing papers in PubMed.

1. B Cell Immunity in Lung Transplant Rejection - Effector Mechanisms and Therapeutic Implications.Frontiers in immunology · 2022
   Review
2. Exosomes Derived from IDO1-Overexpressing Rat Bone Marrow Mesenchymal Stem Cells Promote Immunotolerance of Cardiac Allografts.Cell transplantation · 2018
   Article
3. Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell Immunotherapy.Frontiers in immunology · 2018
   Article
4. Mesenchymal stromal cells in renal transplantation: opportunities and challenges.Nature reviews. Nephrology · 2016
   Review
5. Transplantation tolerance; myth or reality?Journal of nephropathology · 2014
   Article
6. Role of regulatory T cells in transferable immunological tolerance to bone marrow donor in murine mixed chimerism model.Journal of Korean medical science · 2013
   Article
7. Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantation.Journal of transplantation · 2013
   Review
8. Targeting the intragraft microenvironment and the development of chronic allograft rejection.Human immunology · 2012
   Review
9. Innate immunity alone is not sufficient for chronic rejection but predisposes healed allografts to T cell-mediated pathology.Transplant immunology · 2012
   Article
10. De Novo Donor-Specific HLA Antibody Development and Peripheral CD4(+)CD25(high) Cells in Kidney Transplant Recipients: A Place for Interaction?Journal of transplantation · 2012
    Article
11. Castration reverses immunosenescence in aged mice.Acta pharmacologica Sinica · 2011
    Article
12. A multivalent vaccine for type 1 diabetes skews T cell subsets to Th2 phenotype in NOD mice.Immunologic research · 2011
    Article
13. Consecutive low doses of cyclosporine A induce pro-inflammatory cytokines and accelerate allograft skin rejection.Molecules (Basel, Switzerland) · 2011
    Article
14. Noninvasive methods to assess the risk of kidney transplant rejection.Expert review of clinical immunology · 2009
    Article
15. Perception versus reality?: Virtual crossmatch--how to overcome some of the technical and logistic limitations.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2009
    Article
16. Combating chronic renal allograft dysfunction : optimal immunosuppressive regimens.Drugs · 2005
    Review
17. Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance.The Journal of clinical investigation · 2002
    Article
18. A rendezvous before rejection: where do T cells meet transplant antigens?Nature medicine · 2002
    Article
19. STEALTH in transplantation tolerance.Immunologic research · 2002
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as